NCRN033 - Industry trial.

Trial Profile

NCRN033 - Industry trial.

Phase of Trial: Phase II

Latest Information Update: 09 Mar 2011

At a glance

  • Drugs Linifanib; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Apr 2009 Status changed from planning to suspended as reported by United Kingdom Clinical Research Network.
    • 30 Jan 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top